Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kanabo Group's share price for the quarter that ended in Jun. 2024 was €0.0095. Kanabo Group's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 632.43 Mil. Therefore, Kanabo Group's market cap for the quarter that ended in Jun. 2024 was €6.01 Mil.
Kanabo Group's quarterly market cap
declined
from Jun. 2023 (€10.32 Mil) to Dec. 2023 (€7.91 Mil) and
declined
from Dec. 2023 (€7.91 Mil) to Jun. 2024 (€6.01 Mil).
Kanabo Group's annual market cap
declined
from Dec. 2021 (€46.99 Mil) to Dec. 2022 (€8.25 Mil) and
declined
from Dec. 2022 (€8.25 Mil) to Dec. 2023 (€7.91 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kanabo Group's Enterprise Value for Today is €0.10 Mil.
Kanabo Group (STU:3WD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kanabo Group Market Cap Related Terms
Kanabo Group Market Cap Historical Data
* Premium members only.
The historical data trend for Kanabo Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Kanabo Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kanabo Group Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kanabo Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Kanabo Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Kanabo Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kanabo Group (STU:3WD) has a Market Cap of €1.63 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kanabo Group and its competitors.
Is Kanabo Group's Market Cap too high?
Kanabo Group's current Market Cap is €1.63 Mil.
How does Kanabo Group's Market Cap compare to HCA and THC?
Kanabo Group's Market Cap of €1.63 Mil can be compared against companies in the Healthcare Providers & Services industry. The industry median Market Cap is 95.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 95.72, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kanabo Group and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 95.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kanabo Group's current Market Cap is €1.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kanabo Group stock overvalued right now?
Kanabo Group (STU:3WD) has a current Market Cap of €1.63 Mil. The current Market Cap is €1.63 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Kanabo Group (STU:3WD), the current Market Cap is €1.63 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:3WD has been successfully added to your 